Arachidonic acid facilitates experimental chronic osteomyelitis in rats
- J. P. Rissing,
- T. B. Buxton,
- J. Fisher,
- R. Harris,
- R. K. Shockley
- ,
- VA Medical Center,
- Eisenhower Medical Center,
- Medical College of Georgia
Scholary Output:
Contribution to journal
Article
Peer-reviewSustainable Development Goals
SDG 3 Good Health and Well
Abstract
Arachidonic acid was used as a facilitating agent in experimental rat Staphylococcus aureus osteomyelitis and compared with the more commonly used agent, sodium morrhuate. The injection of arachidonic acid or sodium morrhuate and S. aureus into rat tibiae caused increased quantitative bacterial bone counts, gross bone pathology, roentgenographic changes, and weight loss. The doses required to produce these changes appeared to be lower for arachidonic acid.
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 141-144 (4 pages)Journal (Volume, Issue Number)
Infection and Immunity (Volume 49, Issue 1)Publication milestones
- Published - 1985
Publication status
Published - 1985
ISSN
0019-9567Publication IDs
- Scopus: 0021854508
- PubMed: 3924826
Publication metrics
Metrics
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Captures
18
Citation count
34